Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GNMSF) EPS (Basic) (2024 - 2025)

Historic EPS (Basic) for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to -$74.13.

  • Genmab A's EPS (Basic) fell 35321.42% to -$74.13 in Q4 2025 from the same period last year, while for Dec 2025 it was -$74.13, marking a year-over-year decrease of 35321.42%. This contributed to the annual value of $15.5 for FY2025, which is 1223.1% down from last year.
  • Latest data reveals that Genmab A reported EPS (Basic) of -$74.13 as of Q4 2025, which was down 35321.42% from $32.24 recorded in Q3 2025.
  • Genmab A's EPS (Basic)'s 5-year high stood at $79.74 during Q1 2025, with a 5-year trough of -$74.13 in Q4 2025.